Topic of the Month on ModernWeight: Benefits!
Head to the Social Hub to chat on the benefits of GLP-1 medications, including but not limited to weight loss.
AOMs in the News
Weight Loss Drugs: Too Good to Be True?
Link: UCSF Magazine Article
GLP-1 agonists, hailed as wonder drugs for weight loss, come under scrutiny. This article examines their long-term efficacy and safety, raising questions about whether these medications are too good to be true.
Is It Safe to Use Compounded Semaglutide and Tirzepatide for Weight Loss?
Link: Everyday Health Article
With the growing demand for GLP-1 medications, some turn to compounded versions. This article explores the safety and efficacy of compounded semaglutide and tirzepatide, highlighting the potential risks and benefits.
GLP-1 Receptor Agonists and Bariatric Surgery Lower Cancer Risk
Link: ASCO Daily News Article
A recent study reveals that both GLP-1 receptor agonists and bariatric surgery significantly lower the risk of weight-related cancers. This groundbreaking finding could influence future treatment strategies for obesity-related health risks.
GLP-1 Agonists Might Help Control Alcohol Addiction
Link: Wccftech Article
New research suggests that GLP-1 agonists found in Wegovy and Ozempic might help control alcohol addiction. This potential dual benefit could broaden the scope of these medications beyond weight management.
Fractyl Health's GLP-1 Gene Therapy Outperforms Semaglutide in Mice
Fractyl Health's innovative GLP-1 gene therapy has shown superior results compared to semaglutide in mice. This promising development could pave the way for more effective treatments for obesity and related conditions.
Expert Tweet of the Week
From @JAMA_current
"JAMA News in Brief: Semaglutide Lowered Chronic Kidney Disease–Related Risks"
From @JAMASurgery
"Most viewed in the last 7 days: Viewpoint describes potential benefits and hurdles to implementing a more personalized approach to obesity treatment through a comprehensive multidisciplinary evaluation."
---
Our ModernWeight "Weekly Weight Management Insights" newsletter is designed to keep you informed and engaged with the latest in weight management and GLP-1 medications. Visit the Social Hub to join the conversation and connect with our community.
Want to receive this newsletter in your inbox weekly? Create a profile!
Comments